Department of Medicine, Internal Medicine Residency Program, Stanford University, Palo Alto, California.
Cutaneous Hematopathology Clinic, Department of Dermatology, National Institute of Health Sciences and Nutrition, Mexico City, Mexico.
JAMA Dermatol. 2022 Aug 1;158(8):954-956. doi: 10.1001/jamadermatol.2022.2100.
This cohort study of data from 39 patients assesses whether the presence of a dominant T-cell receptor clone in peripheral blood is associated with time to systemic treatment in patients with stage IB mycosis fungoides.
本队列研究对 39 例患者的数据进行评估,旨在考察外周血中优势 T 细胞受体克隆的存在是否与蕈样肉芽肿病 IB 期患者接受全身治疗的时间有关。